Skip to main content

Table 1 Demographics and clinical characteristics

From: Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience

Demographic and characteristics

Values

Age (years), mean

55.7

Male sex, n (%)

23 (76.7)

Race, n (%)

 Malay

15 (50)

 Chinese

13 (43.3)

 Indian

2 (6.7)

Smoking History, n (%)

 Active smoker

9 (30)

 Ex- smoker

9 (30)

 Non smoker

12 (40)

 Comorbidities, n (%)

30 (100)

Cardiovascular disease

 Hypertension

17 (56.7)

 Ischemic heart disease

5 (16.7)

 Atrial fibrillation

1 (3.6)

 Congestive cardiac failure

2 (7.1)

Endocrine disease

 Diabetes mellitus

14 (46.7)

Respiratory disease

 Pulmonary tuberculosis (in the past)

2 (6.7)

Neurological disease

 Stroke

3 (10)

Renal disease

 Chronic kidney disease

3 (2 on dialysis) (10)

Malignancy

 Lung malignancy

2 (6.7)

 Haematological malignancy

1 (3.3)

 Retroperitoneal liposarcoma

1 (3.3)

Other

 HIV

2 (6.7)

 Thalassemia major

1 (3.3)

Pleural infection characteristics

 Ultrasonographic evidence of septations, n (%)

30 (100)

Pleural fluid analysis

 Bacteria identified in pleural fluid culture, n (%)

8 (26.7)

 Median LDH, U/L (IQR)

1034 (550–4395)

 Median pleural fluid glucose, mmol/L (IQR)

4.9 (1.4–7.9)

 Mean pleural fluid pH (SD)

8.0 ± 0.49

Intercostal catheter

  > 1 intercostal catheter, n (%)

11 (36.7)

 Small bore intercostal catheter, ≤ 15 French, n (%)

26 (86.7)

  1. IQR interquartile range, SD standard deviation, LDH lactate dehydrogenase, ULN upper limit of normal